Cicatricial Alopecias and the Role of Janus Kinase Inhibitors: A Novel Approach and Comprehensive Overview to a Challenging Problem
Canadian Dermatology Today · 2025
DOI: 10.58931/cdt.2025.62143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Dermatology Today, 2025. Verfasst von Marisa G. Ponzo. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Cicatricial alopecias (CAs) represent a group of conditions that result in permanent hair loss due to the destruction of hair follicles and their replacement with scar tissue. Recently, Janus kinase (JAK) inhibitors have emerged as potential treatments for various alopecias, including scarring types. In this review, we will discuss CAs, their pathophysiology, diagnosis, and the evolving role of JAK inhibitors in their treatment.
Zitieren
APA
Ponzo, M. G. (2025). Cicatricial Alopecias and the Role of Janus Kinase Inhibitors: A Novel Approach and Comprehensive Overview to a Challenging Problem. Canadian Dermatology Today. https://doi.org/10.58931/cdt.2025.62143
Vancouver
Ponzo MG. Cicatricial Alopecias and the Role of Janus Kinase Inhibitors: A Novel Approach and Comprehensive Overview to a Challenging Problem. Canadian Dermatology Today. 2025. doi:10.58931/cdt.2025.62143
BibTeX
@article{Ponzo2025,
author = {Ponzo, Marisa G.},
title = {Cicatricial Alopecias and the Role of Janus Kinase Inhibitors: A Novel Approach and Comprehensive Overview to a Challenging Problem},
journal = {Canadian Dermatology Today},
year = {2025},
doi = {10.58931/cdt.2025.62143}
}
EUVIMED